Urivoid Tablet, containing the active ingredient bethanechol, is a prescription medication used to treat urinary retention. It works by stimulating the bladder muscles to promote urination, thereby aiding in the emptying of the bladder. Bethanechol is commonly prescribed for conditions such as postoperative or postpartum urinary retention and neurogenic bladder disorders NCBI.

Key Benefits & Uses

• Stimulates Bladder Contraction: Enhances the ability to urinate by promoting bladder muscle contractions.

• Treats Urinary Retention: Effective in managing urinary retention caused by surgery, childbirth, or neurological conditions.

• Improves Bladder Emptying: Assists in complete bladder emptying, reducing the risk of urinary tract infections.

• Non-Obstructive Use: Specifically used when urinary retention is not due to a physical blockage DrugBank.

How to Use

Urivoid Tablet should be taken orally, typically 3 to 4 times a day. It is recommended to take the medication on an empty stomach—either 1 hour before or 2 hours after meals—to minimize potential stomach upset MedlinePlus. Always follow the dosing instructions provided by your healthcare provider.

Important Safety Information

• Allergic Reactions: Seek immediate medical attention if you experience symptoms such as rash, itching, swelling, or difficulty breathing.

• Medical History: Inform your doctor if you have a history of asthma, heart conditions, peptic ulcers, or gastrointestinal obstructions.

• Pregnancy and Breastfeeding: Consult your healthcare provider before using Urivoid Tablet if you are pregnant or breastfeeding.

• Drug Interactions: Discuss all medications you are taking with your doctor, as certain drugs may interact with bethanechol Cleveland Clinic.

Common Side Effects

• Nausea

• Diarrhea

• Abdominal discomfort

• Increased salivation

• Sweating

• Headache

• Dizziness

If any of these side effects persist or worsen, contact your healthcare provider promptly Drugs.com.

Why Choose Urivoid Tablet?

Urivoid Tablet offers a targeted approach to managing urinary retention without affecting the central nervous system, as it does not cross the blood-brain barrier. This minimizes the risk of central side effects. Its effectiveness in stimulating bladder contractions makes it a reliable choice for individuals experiencing non-obstructive urinary retention NCBI.